Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

599 ARTÍCULOS , VIENDO DEL 286 AL 300

Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study

Payne T, Sassani M, Buckley E, Moll S, Anton A, Appleby M, Maru S, Taylor R, McNeill A, Hoggard N, Mazza C, Wilkinson ID, Jenkins T, Foltynie T, Bandmann O.

BMJ Open. 2020 Aug 5;10(8):e038911. doi: 10.1136/bmjopen-2020-038911.

Double-Blind, Randomized, Placebo-Controlled Trial of DA-9701 in Parkinson's Disease: PASS-GI Study

Choi JH, Lee JY, Cho JW, Koh SB, Yang YS, Yoo D, Shin CM, Kim HT.

Mov Disord. 2020 Nov;35(11):1966-1976. doi: 10.1002/mds.28219. Epub 2020 Aug 6.

Auditory and Olfactory Deficits in Essential Tremor - Review of the Current Evidence

Sengul Y.

Tremor Other Hyperkinet Mov (N Y). 2020 Jun 9;10:3. doi: 10.5334/tohm.57.

Unilateral leg freezing in moyamoya syndrome

Phattranonuthai R, Frucht SJ, Termsarasab P.

Parkinsonism Relat Disord. 2020 Sep;78:96-97. doi: 10.1016/j.parkreldis.2020.06.024. Epub 2020 Jul 31.

Recognising hemihypomimia as a mimic of 'facial weakness'

Phillips O, D'Abreu A, Friedman JH, Akbar U.

J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1357-1358. doi: 10.1136/jnnp-2020-323201. Epub 2020 Aug 11.

Recent developments in the treatment of Parkinson's Disease

Stoker TB, Barker RA.

F1000Res. 2020 Jul 31;9:F1000 Faculty Rev-862. doi: 10.12688/f1000research.25634.1. eCollection 2020.

An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression

DeKarske D, Alva G, Aldred JL, Coate B, Cantillon M, Jacobi L, Nunez R, Norton JC, Abler V.

J Parkinsons Dis. 2020;10(4):1751-1761. doi: 10.3233/JPD-202058.

Current Perspectives on Aerobic Exercise in People with Parkinson's Disease

Schootemeijer S, van der Kolk NM, Bloem BR, de Vries NM.

Neurotherapeutics. 2020 Oct;17(4):1418-1433. doi: 10.1007/s13311-020-00904-8.

Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities

Olanow CW, Calabresi P, Obeso JA.

Mov Disord. 2020 Oct;35(10):1731-1744. doi: 10.1002/mds.28215. Epub 2020 Aug 20.

Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

Martí-Andrés G, van Bommel L, Meles SK, Riverol M, Valentí R, Kogan RV, Renken RJ, Gurvits V, van Laar T, Pagani M, Prieto E, Luquin MR, Leenders KL, Arbizu J.

Mov Disord. 2020 Nov;35(11):2009-2018. doi: 10.1002/mds.28217. Epub 2020 Aug 21.

Transcranial Magnetic Stimulation Promotes Gait Training in Parkinson Disease

Chung CL, Mak MK, Hallett M.

Ann Neurol. 2020 Nov;88(5):933-945. doi: 10.1002/ana.25881. Epub 2020 Sep 8.

Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy

Stuart S, Morris R, Giritharan A, Quinn J, Nutt JG, Mancini M.

Mov Disord. 2020 Nov;35(11):2019-2027. doi: 10.1002/mds.28214. Epub 2020 Aug 24.

Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review

Rosca EC, Simu M.

Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588.

The MPTP-lesioned marmoset model of Parkinson's disease: proposed efficacy thresholds that may potentially predict successful clinical trial results

Beaudry F, Huot P.

J Neural Transm (Vienna). 2020 Oct;127(10):1343-1358. doi: 10.1007/s00702-020-02247-2. Epub 2020 Aug 29.

Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease

Marchetti B.

Redox Biol. 2020 Sep;36:101664. doi: 10.1016/j.redox.2020.101664. Epub 2020 Aug 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias